Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma

Digestive Diseases

Volumn 27, Issue 2, 2009, Pages 170-174

  Mohnike, Konrad ^a   Wieners, Gero ^a   Pech, Maciej ^a   Seidensticker, Max ^a   Rühl, Ricarda ^a   Lopez Haenninen, Enrique ^b   Ricke, Jens ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Image guided brachytherapy; Image guided interstitial high dose rate brachytherapy

Indexed keywords

SORAFENIB;

BLEEDING; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INFECTION; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA EFFUSION; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME; ULCER;

BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650938399     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218350     Document Type: Review

References (33)

1. Jaeck D, Bachellier P, Oussoultzoglou E, Weber JC, Wolf P: Surgical resection of hepato- cellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. Liver Transpl 2004;10(suppl 1):S58-S63.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al: Liver transplantation for the treatment of small hepato- cellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
3. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-928.
4. Oquinena S, Inarrairaegui M, Vila JJ, Alegre F, Zozaya JM, Sangro B: Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature. Dig Dis Sci 2009;54:1147-1153.
5. Randolph AC, Tharalson EM, Gilani N: Spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies. Eur J Gastroenterol Hepatol 2008;20:804-809.
6. Sibartie V, Moriarty J, Crowe J: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 2008;103:1050-1051.
7. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.
8. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellu- lar carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
9. Helmberger T, Dogan S, Straub G, Schrader A, Jungst C, Reiser M, et al: Liver resection or combined chemoembolization and radio- frequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 2007; 75: 104-112.
10. Lopez PM, Villanueva A, Llovet JM: Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006;23:1535-1547.
11. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ: Radiofre- quency ablation of liver tumors: a systematic review. Arch Surg 2006;141:181-190.
12. Llovet JM, Sala M, Bruix J: Nonsurgical treatment of hepatocellular carcinoma. Liver Transpl 2000;6(6 suppl 2):S11-S15.
13. Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, et al: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005; 23: 8739-8747.
14. Antoch G, Kaiser GM, Mueller AB, Metz KA, Zhang H, Kuehl H, et al: Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CT. Radiology 2004;230:753-760.
15. Thomas DS, Nauta RJ, Rodgers JE, Popescu GF, Nguyen H, Lee TC, et al: Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 1993;71: 1977-1981.
16. Dritschilo A, Harter KW, Thomas D, Nauta R, Holt R, Lee TC, et al: Intraoperative radiation therapy of hepatic metastases: technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys 1988;14:1007-1011.
17. Holt RW, Nauta RJ, Lee TC, Heres EK, Dritschilo A, Harter KW, et al: Intraopera- tive interstitial radiation therapy for hepatic metastases from colorectal carcinomas. Am Surg 1988; 54:231-233.
18. Nauta RJ, Heres EK, Thomas DS, Harter KW, Rodgers JE, Holt RW, et al: Intraoperative single-dose radiotherapy. Observations on staging and interstitial treatment of unre- sectable liver metastases. Arch Surg 1987; 122:1392-1395.
19. Dritschilo A, Harter KW, Thomas D, Nauta R, Holt R, Lee TC, et al: Intraoperative radiation therapy of hepatic metastases: technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys 1988;14:1007-1011.
20. Dritschilo A, Grant EG, Harter KW, Holt RW, Rustgi SN, Rodgers JE: Interstitial radiation therapy for hepatic metastases: sono- graphic guidance for applicator placement. AJR Am J Roentgenol 1986;147:275-278.
21. Bergk A, Wieners G, Weich V, Wiedenmann B, Berg T, Ricke J: CT-guided brachytherapy of hepatocellular carcinoma in liver cirrhosis - a novel therapeutic approach. J Hepatol 2005;42:89.
22. Ricke J, Wust PG, Werk M, Pech M, Beck AN, Stohlmann A: CT-guided brachytherapy of liver metastasis alone or in combination with laser-induced thermotherapy: safety and efficacy. Radiology 2002;225:447.
23. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, et al: Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15:12791286.
24. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al: CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004; 58:1496-1505.
25. Ricke J, Wust P, Wieners G, Hengst S, Pech M, Lopez HE, et al: CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest 2005; 127: 2237-2242.
26. Wieners G, Pech M, Rudzinska M, Lehm- kuhl L, Wlodarczyk W, Miersch A, et al: CT- guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 2006; 16: 2586-2593.
27. 18F-fluorodeoxyglucose on therapeutic decisions. Nuklearmedizin 2006;45: 177-184.
28. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al: CT-guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver malignancies. Strahlen- ther Onkol 2004;180:274-280.
29. Pech M, Wieners G, Kryza R, Dudeck O, Sei- densticker M, Mohnike K, et al: CT-guided brachytherapy versus interstitial laser ablation of colorectal liver metastases: an intra- individual matched-pair analysis. Strahlen-ther Onkol 2008; 184: 302-306.
30. Streitparth F, Pech M, Bohmig M, Ruehl R, Peters N, Wieners G, et al: In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006;65:1479-
31. Ricke J, Seidensticker M, Ludemann L, Pech M, Wieners G, Hengst S, et al: In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 2005; 62: 776-784.
32. Ricke J: Interventional therapy for liver me- tastases. Z Gastroenterol 2004; 42:1321-1328.
33. Schwarz RE, Smith DD: Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008;195:829-836.